MedTrace Logo

Clinical Trial of CoQ10 for Mild-to-Moderate Statin-Associated Muscle Symptoms

NCT01032993 · Status: COMPLETED · Phase: PHASE2/PHASE3 · Type: INTERVENTIONAL · Enrollment: 68

Last updated 2017-01-23

Study results available
· View outcomes & findings →

Summary

This study will evaluate whether a dietary supplement, coenzyme Q10 (CoQ10), will improve muscle symptoms, such as muscle aches, pains, cramps, and/or weakness, which are experienced by some individuals who use statin medications.

Conditions

  • Pain
  • Weakness
  • Cramps
  • Myalgia or Myositis Nos
  • HMG COA Reductase Inhibitor Adverse Reaction

Interventions

DIETARY_SUPPLEMENT

Coenzyme Q10

300 mg of CoQ10 (three 100 mg chewable tablets) 2 times daily for 4 weeks

OTHER

Placebo

Placebo (three chewable tablets) 2 times daily for 4 weeks

Sponsors & Collaborators

  • National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)

    collaborator NIH

  • Catherine Buettner

    lead OTHER

Principal Investigators

  • Catherine Buettner, MD, MPH · Beth Israel Deaconess Medical Center

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
21 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2009-12-31
Primary Completion
2016-05-31
Completion
2016-05-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01032993 on ClinicalTrials.gov